title: Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient withRCSD1-ABL1-positive acute lymphoblastic leukemia.
authors.affiliation: Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany.
authors.forename: Miriam
authors.initials: M
authors.lastname: Frech
authors.affiliation: Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany.
authors.forename: Lutz B
authors.initials: LB
authors.lastname: Jehn
authors.affiliation: Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany.
authors.forename: Kathleen
authors.initials: K
authors.lastname: Stabla
authors.affiliation: Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacher Straβe 6, Germany.
authors.forename: Stephan
authors.initials: S
authors.lastname: Mielke
authors.affiliation: Department of Medicine, Hematology/Oncology, Goethe University of Frankfurt, Theodor-Stern-Kai 7, Germany.
authors.forename: Björn
authors.initials: B
authors.lastname: Steffen
authors.affiliation: Department of Internal Medicine II, University Hospital Würzburg, Oberdürrbacher Straβe 6, Germany.
authors.forename: Hermann
authors.initials: H
authors.lastname: Einsele
authors.affiliation: Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany.
authors.forename: Stephan K
authors.initials: SK
authors.lastname: Metzelder
authors.affiliation: Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Baldingerstrasse, Germany neubauer@staff.uni-marburg.de.
authors.forename: Andreas
authors.initials: A
authors.lastname: Neubauer
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001483:Base Sequence; D000069439:Dasatinib / Q000627:therapeutic use*; D005260:Female; D015870:Gene Expression; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D016315:Proto-Oncogene Proteins c-abl / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D014178:Translocation, Genetic; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D047908:Intracellular Signaling Peptides and Proteins; D015514:Oncogene Proteins, Fusion; C506059:RCSD1 protein, human; D016315:Proto-Oncogene Proteins c-abl; D000069439:Dasatinib